Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on June 21, 2002; DOI 10.1182/blood-2002-01-0055.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-01-0055v1
100/9/3261    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mace, G.
Right arrow Articles by Dietrich, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mace, G.
Right arrow Articles by Dietrich, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted January 8, 2002
Accepted June 11, 2002

Anti-µ opioid receptor IgG antibodies are commonly present in serum of healthy blood donors : evidence for a role in apoptotic immune cell death

Gaetane Mace, Martial Jaume, Catherine Blanpied, Lionel Stephan, Jerome D Coudert, Philippe Druet, and Gilles Dietrich*

Oncogenesis and signaling in haematopoietic cells, INSERM U563, Toulouse, France

* Corresponding author; email: Gilles.Dietrich{at}toulouse.inserm.fr.

We have previously shown the presence of anti-human µ opioid receptor autoantibodies within IgG pools prepared from several thousands of healthy blood donors. These autoantibodies behaved agonistically due to their ability to bind to the first and the third extracellular loops of the receptor. In this study, we show that each healthy donor's serum contains anti-µ opioid receptor IgG autoantibodies exhibiting a specific activity against both the first and the third extracellular loops of the receptor. Because of the inability of IgG to cross the blood-brain barrier, we investigated the consequences of the expression of anti-human µ opioid receptor autoantibodies on immune cells. By analogy to morphine effects, we investigated the ability of antibodies to sensitize splenocytes to Fas (CD95)-mediated apoptosis. We took advantage of the high sequence homology between mouse and human µ opioid receptor extracellular loops to estimate the effect on mouse splenocytes of anti-human µ opioid receptor antibodies raised by immunizing mice. Splenocytes from mice injected with µ-opioid receptor-expressing CHO cells were sensitized to Fas-mediated apoptosis while those from mice injected with CHO cells or PBS were not. Similar sensitization to Fas-mediated apoptosis was observed in splenocytes from mice passively transferred either with IgG from mice previously immunized against µ-opioid receptor-expressing CHO cells, or with IgG directed against the first and the third extracellular loops of the receptor. Taken together, our data show that anti-µ-opioid receptor autoantibodies are commonly expressed in healthy humans and could participate to the control of lymphocyte homeostasis by promoting Fas-mediated apoptosis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020